Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avastin and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme: A Phase II Study

NCT00590681 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00590681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00590681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avastin and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme: A Phase II Study
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
September 30, 2014
Enrollment
62 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme